Cancer Mortality in Six Lowest Versus Six Highest Elevation Jurisdictions in the U. S

Hart, John
January 2011
Dose-Response;2011, Vol. 9 Issue 1, p50
Academic Journal
Low levels of background radiation exist around us continuously. These levels increase with increasing land elevation, allowing a comparison of low elevations to high elevations in regard to an outcome such as cancer death rates. The present study compares archived cancer mortality rates in six low versus six high elevation jurisdictions. The study also compares mortality rates for all causes, heart disease, and diabetes in low versus high elevation jurisdictions in an effort to see if other mortality outcomes are different in low versus high elevations. Statistically significant decreases in mortality, with very large effect sizes, were observed in high land elevation for three of the four outcomes, including cancer. One possible explanation for the decreased mortality in high elevation jurisdictions is radiation hormesis. Another possible explanation, at least in the case of heart disease mortality, is the physiologic responses that accompany higher elevations regarding decreased oxygen levels. Since this is an ecological study, no causal inferences can be made, particularly when viewpoints on possible effects of low level radiation are diametrically opposed. Further research is indicated.


Related Articles

  • Pure germinomas of the central nervous system: treatment strategies and outcomes. Schoenfeld, Adam; Haas-Kogan, Daphne; Molinaro, Annette; Banerjee, Anu; Nicolaides, Theodore; Tihan, Tarik; Bollen, Andrew; Gupta, Nalin; Mueller, Sabine // Journal of Neuro-Oncology;Dec2014, Vol. 120 Issue 3, p643 

    To evaluate the role of chemotherapy and radiation therapy in the treatment of pure germinomas of the central nervous system (CNS). We reviewed a historical cohort of 79 patients between the ages of 3-35 years who received definitive treatment for newly diagnosed, pure CNS germinoma between 1985...

  • Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study. Yang, Ching-Chieh; Chen, Po-Chun; Hsu, Chia-Wen; Chang, Shih-Lun; Lee, Ching-Chih // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Purpose: To characterize the impact of comorbidity on survival outcomes for patients with nasopharyngeal carcinoma (NPC) post radiotherapy (RT). Methods: A total of 4095 patients with NPC treated by RT or RT plus chemotherapy (CT) in the period from 2007 to 2011 were included through...

  • Surgical Outcome of Mandibular Swing Approach for Infratemporal Fossa Tumors. Bajaj, Jitin; Mishra, Arpan; Pateriya, Anurag; Yadav, Yadram; Ratre, Shailendra; Parihar, Vijay // Indian Journal of Neurosurgery;2016, Vol. 5 Issue 3, p159 

    Introduction: There are numerous approaches for infratemporal fossa tumors with their own pros and cons. Mandibular swing approach is simple and provides ample exposure. We describe 10 cases of these masses operated using this approach. Materials and Methods: It was a retrospective study in the...

  • Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma. Lesser, Robert L // British Journal of Ophthalmology;May2010, Vol. 94 Issue 5, p559 

    BACKGROUND/AIMS: To review the long-term results of treatment of optic nerve sheath meningiomas (ONSMs) with conformal radiotherapy. METHODS: Eleven patients with presumed ONSM were treated with fractionated conformal radiotherapy using 45–54 Gy in 25–30 fractions and followed...

  • Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Takigawa, N.; Kiura, K.; Segawa, Y.; Watanabe, Y.; Kamei, H.; Moritaka, T.; Shibayama, T.; Ueoka, H.; Gemba, K.; Yonei, T.; Tabata, M.; Shinkai, T.; Hiraki, S.; Takemoto, M.; Kanazawa, S.; Matsuo, K.; Tanimoto, M. // British Journal of Cancer;11/6/2006, Vol. 95 Issue 9, p1142 

    Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was...

  • Analysis of the surgical treatment for superior sulcus tumors. Ichiki, Yoshinobu; Nagashima, Akira; Yasuda, Manabu; Takenoyama, Mitsuhiro // Surgery Today;Dec2013, Vol. 43 Issue 12, p1419 

    Purpose: This study was undertaken to assess the mortality, complication, and major morbidity rates of surgical treatment for superior sulcus tumors (SSTs), and to estimate the significance of prognostic factors. Methods: We retrospectively reviewed the hospital records of 50 consecutive...

  • Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study. Parpia, Sameer; Thabane, Lehana; Julian, Jim A.; Whelan, Timothy J.; Levine, Mark N. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background: Subjects with breast cancer enrolled in trials may experience multiple events such as local recurrence, distant recurrence or death. These events are not independent; the occurrence of one may increase the risk of another, or prevent another from occurring. The most commonly used Cox...

  • Mortality Risk After Preoperative Versus Postoperative Chemotherapy and Radiotherapy in Lymph Node-Positive Rectal Cancer. Seery, Tara; Ziogas, Argyrios; Lin, Bruce; Pan, Chuan-Ju; Stamos, Michael; Zell, Jason // Journal of Gastrointestinal Surgery;Feb2013, Vol. 17 Issue 2, p374 

    Introduction: Persistent lymph node-positive disease after preoperative radiotherapy for rectal cancer is associated with adverse outcomes. We quantified mortality risks of persistent pathologic lymph nodes in lymph node-positive rectal cancer patients treated with preoperative versus...

  • Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol. Habl, Gregor; Jensen, Alexandra D.; Potthoff, Karin; Uhl, Matthias; Hof, Holger; Hajda, Jacek; Simon, Christian; Debus, Jürgen; Krempien, Robert; Münter, Marc W. // BMC Cancer;2010, Vol. 10, p651 

    Background: Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combined therapy is intensified by the addition of the EGFR inhibitor cetuximab...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics